Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
ESC Heart Failure|April 6, 2026
Association Between Functional Status and Cardiac Function in Chronic Heart Failure: Insights from the C-MIC II TrialMarat Fudim, Tamara Kovacevic-Preradovic, Marija Zdravkovic, et al.Journal of Cardiac Failure|August 16, 2025
Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF)Maja Cikes, Ivo Planinc, Jasper J Brugts, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2012
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and strokeBruno Barsic, Stuart Dickerman, Vladimir Krajinovic, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 29, 2022
A multicentre, propensity score matched analysis comparing a valve-sparing approach to valve replacement in aortic root aneurysm: Insight from the AVIATOR databaseBardia Arabkhani, Robert J M Klautz, Frederiek de Heer, et al.Heart, Lung & Circulation|January 22, 2026
Does Preoperative Left Ventricular Ejection Fraction Impact the Results After Aortic Root Surgery? Decision-Making Between Aortic Valve-Sparing Techniques and Bentall OperationCarlotta Brega, Diego Sangiorgi, Mikita Karalko, et al.JACC. Heart Failure|September 2, 2025
Angiotensin-Neprilysin Inhibition and Left Ventricular Assist Device Therapy -Primary results of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 LVAD recipients (ENVAD-HF)Maja Cikes, Jasper J Brugts, Brian Claggett, et al.European Journal of Heart Failure|July 15, 2025
Cardio-microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C-MIC II open-label randomized controlled trialJesus E Rame, Jan D Schmitto, Dragana N Kosevic, et al.Toxicology|December 14, 2024
Myocardial deposition of aluminum, arsenic, cadmium, and lead accelerates heart failure and alters UPRmt in humansTomo Svagusa, Natalija Matic, Vid Mirosevic, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 10, 2018
Heart re-transplantation in EurotransplantJacqueline M Smits, Michel De Pauw, Uwe Schulz, et al.Pageof 5